Eric Dillon’s Journey with Multiple Myeloma
Eric Dillon initially attributed his shoulder pain to a strained rotator cuff. An orthopedic visit seemed to support this assumption with physical therapy helping alleviate the discomfort. Although the pain became a part of his daily routine, he managed it by adjusting his sleep position and activity levels.
However, in May 2024, Dillon experienced a burst of significant pain while doing yard work. Another trip to the orthopedist revealed something concerning, leading to a referral to an oncologist. Dillon was unaware of the implications. The oncologist explained, “I’m an orthopedic oncologist… I do cancer.” Tests soon confirmed that Dillon had multiple myeloma, a type of blood cancer affecting plasma cells.
Multiple myeloma disrupts normal blood formation, causing anemia, kidney damage, and higher calcium levels. It can also damage bones, which explained Dillon’s shoulder pain. Dr. Hearn Cho, of the Multiple Myeloma Research Foundation, noted that misdiagnosis as an injury is common since symptoms often mimic more common issues like back pain.
Dillon’s diagnosis shocked him, though he knew about the disease from a cousin and a college friend who also had it. He learned that Black Americans are disproportionately affected. Though around 4% of the U.S. population, they make up roughly 20% of multiple myeloma cases, often developing the disease earlier.
Eager to start treatment, Dillon felt reassured by having a plan. He joined a clinical trial willingly, viewing it as a chance to contribute and gain understanding. Cho identified Black patients as underrepresented in trials, though the disease is more prevalent in their communities.
Dillon underwent eight cycles of treatment over nearly a year, adjusting his work schedule as needed. He kept a journal, detailing minor side effects which led to dosage adjustments. The trial proceeded well with no significant side effects. Following the trial, additional radiation treatments eradicated remaining cancer in his shoulder, and the pain subsided.
In remission, Dillon now has regular oncology check-ups and takes daily medication to maintain his health. While he might consider a stem cell replacement in the future, he currently prefers to cherish time with his family, including celebrating a new grandchild.
Dillon aims to raise awareness about multiple myeloma’s uncommon symptoms and the tools for faster diagnosis. He collaborates with the Multiple Myeloma Research Foundation and encourages others, like a friend diagnosed similarly, to get involved. “This is not one of those cancers that there’s no treatment for,” Dillon emphasized. “The future is bright.”